M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
Authors
Keywords
M-CSF, HE4, CA 125, Epithelial ovarian cancer, Tumor markers
Journal
Journal of Ovarian Research
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-02
DOI
10.1186/s13048-015-0153-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients
- (2013) S Ławicki et al. Advances in Medical Sciences
- Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
- (2013) Amal Z. Azzam et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
- (2013) Elham O Hamed et al. Diagnostic Pathology
- VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve
- (2013) Sławomir Ławicki et al. GROWTH FACTORS
- HE4 combined with CA125: favorable screening tool for ovarian cancer
- (2013) Nasrin Ghasemi et al. MEDICAL ONCOLOGY
- The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors
- (2013) Sławomir Ławicki et al. Journal of Ovarian Research
- Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer
- (2012) Chan-zhen Liu et al. Chinese Journal of Cancer Research
- Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients
- (2012) Sławomir Ławicki et al. GROWTH FACTORS
- Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome
- (2012) M.T. Sandri et al. GYNECOLOGIC ONCOLOGY
- The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass
- (2012) Karen K.L. Chan et al. GYNECOLOGIC ONCOLOGY
- Serum HE4 as a Useful Biomarker in Discriminating Ovarian Cancer From Benign Pelvic Disease
- (2012) Hong Zheng et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Utility of Human Epididymal Protein 4, Cancer Antigen 125, and Risk for Malignancy Algorithm in Ovarian Cancer and Endometriosis
- (2012) Sasa Kadija et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions
- (2012) Ronalds Macuks et al. TUMOR BIOLOGY
- Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women
- (2011) Kevin Holcomb et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
- (2011) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Relationship between the Expression of VEGF Signal Components and Matrix Metalloproteinases in Ovarian Tumors
- (2011) E. S. Gershtein et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
- (2011) Samar Masoumi Moghaddam et al. CANCER AND METASTASIS REVIEWS
- HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm
- (2011) Giuseppina Ruggeri et al. CLINICA CHIMICA ACTA
- Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases
- (2011) Yongjung Park et al. CLINICAL BIOCHEMISTRY
- Hematopoietic cytokines as tumor markers in gynecological malignancies: A multivariate analysis with ROC curve in endometrial cancer patients
- (2011) Sławomir Ławicki et al. GROWTH FACTORS
- Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
- (2011) Michèl Schummer et al. GYNECOLOGIC ONCOLOGY
- The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines
- (2011) Andrea Morandi et al. PLoS One
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- (2011) Rafael Molina et al. TUMOR BIOLOGY
- TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
- (2010) Sven Mahner et al. BMC CANCER
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
- (2010) Brian Nolen et al. GYNECOLOGIC ONCOLOGY
- Development of a Multimarker Assay for Early Detection of Ovarian Cancer
- (2010) Zoya Yurkovetsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study
- (2009) Garnet L. Anderson et al. JNCI-Journal of the National Cancer Institute
- A serum based analysis of ovarian epithelial tumorigenesis
- (2008) Brian Nolen et al. GYNECOLOGIC ONCOLOGY
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Effect ofBRCA1/2Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer
- (2007) Angela Chetrit et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More